The number of live influenza surveillance cases worldwide reached a peak in nearly 10 years at the end of 2022, and has been stable at a low level since February 2023, with the main prevalent strain being type A.
It is intended for detection of influenza A & B viral nucleoprotein antigens in samples from individuals suspected of respiratory viral infection.